Saratov secures 145,650 insulin aspart doses for beneficiaries by 2026

Saratov secures 145,650 insulin aspart doses for beneficiaries by 2026

Saratov Health Ministry to Purchase Insulin for Beneficiaries Worth 17.4 Million Rubles

Saratov secures 145,650 insulin aspart doses for beneficiaries by 2026

The Saratov Regional Health Ministry has announced plans to purchase insulin aspart for beneficiaries. The move aims to ensure a steady supply of the medication for those in need. Funding for the procurement comes from the regional budget under the 2026 'Healthcare Development' programme. A total of 145,650 doses of insulin aspart will be acquired. Each dose is priced at 119.68 rubles, bringing the total cost to 17.43 million rubles. The delivery deadline is set for August 25, 2026, with all supplies directed to the Saratov Pharmaceutical Warehouse.

The funds for this purchase are specifically allocated from the regional budget. This supports the ongoing state programme focused on improving healthcare services in the region. The insulin aspart procurement will provide essential medication to beneficiaries in Saratov. The delivery must be completed by the specified date to meet the programme’s requirements. The regional budget covers the full cost of the purchase.

Neueste Nachrichten